4Filing Date: Sep 15, 2026

West Pharmaceutical Services (WST)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0000105770-26-000110
Total Value$3.35M
Trades9
Insiders1

Transaction Details

Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Exercise · Acquire
Common Stock
Shares+2.52K
Price$89.64
Total Value$226.3K
Shares Owned After24.34K
Transaction DateSep 15, 2026
10b5-1
Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Sell · Dispose
Common Stock
Shares-2.52K
Price$365.00
Total Value$921.3K
Shares Owned After21.82K
Transaction DateSep 15, 2026
10b5-1
Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Exercise · Dispose
Stock Option (Right to Buy)Derivative
Shares-2.52K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateSep 15, 2026
Exercise Price$89.64
ExpiresFeb 20, 2028
10b5-1
Footnotes ▸

This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.

Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Exercise · Acquire
Common Stock
Shares+2.50K
Price$89.64
Total Value$224.1K
Shares Owned After24.32K
Transaction DateSep 14, 2026
10b5-1
Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Sell · Dispose
Common Stock
Shares-2.50K
Price$355.00
Total Value$887.5K
Shares Owned After21.82K
Transaction DateSep 14, 2026
10b5-1
Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Exercise · Dispose
Stock Option (Right to Buy)Derivative
Shares-2.50K
Price$0.00
Total Value$0
Shares Owned After2.52K
Transaction DateSep 14, 2026
Exercise Price$89.64
ExpiresFeb 20, 2028
10b5-1
Footnotes ▸

This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.

Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Exercise · Acquire
Common Stock
Shares+2.50K
Price$89.64
Total Value$224.1K
Shares Owned After24.32K
Transaction DateSep 11, 2026
10b5-1
Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Sell · Dispose
Common Stock
Shares-2.50K
Price$345.00
Total Value$862.5K
Shares Owned After21.82K
Transaction DateSep 11, 2026
10b5-1
Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Exercise · Dispose
Stock Option (Right to Buy)Derivative
Shares-2.50K
Price$0.00
Total Value$0
Shares Owned After5.02K
Transaction DateSep 11, 2026
Exercise Price$89.64
ExpiresFeb 20, 2028
10b5-1
Footnotes ▸

This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.

Post-Transaction Holdings

Favorite Annette F · Sr. VP & Chief HR Officer
SecuritySharesChange
Common Stock24.34K-
Stock Option (Right to Buy)0-7.52K (-100.00%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-11 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: WEST PHARMACEUTICAL SERVICES INC (WST) CIK: 0000105770 --- Reporting Owner --- Name: Favorite Annette F CIK: 0001654975 Role: Officer (Sr. VP & Chief HR Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-09-11 | Code: M (Exercise of derivative) Shares: +2,500 | Price: $89.64 Total Value: $224,100.00 Shares Owned After: 24,317.8098 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-09-11 | Code: S (Open market sale) Shares: -2,500 | Price: $345.00 Total Value: $862,500.00 Shares Owned After: 21,817.8098 | Ownership: D (Direct) [Transaction #3] Security: Common Stock Date: 2026-09-14 | Code: M (Exercise of derivative) Shares: +2,500 | Price: $89.64 Total Value: $224,100.00 Shares Owned After: 24,317.8098 | Ownership: D (Direct) [Transaction #4] Security: Common Stock Date: 2026-09-14 | Code: S (Open market sale) Shares: -2,500 | Price: $355.00 Total Value: $887,500.00 Shares Owned After: 21,817.8098 | Ownership: D (Direct) [Transaction #5] Security: Common Stock Date: 2026-09-15 | Code: M (Exercise of derivative) Shares: +2,524 | Price: $89.64 Total Value: $226,251.36 Shares Owned After: 24,341.8098 | Ownership: D (Direct) [Transaction #6] Security: Common Stock Date: 2026-09-15 | Code: S (Open market sale) Shares: -2,524 | Price: $365.00 Total Value: $921,260.00 Shares Owned After: 21,817.8098 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Stock Option (Right to Buy) Date: 2026-09-11 | Code: M (Exercise of derivative) Shares: -2,500 | Price: $0.00 Exercise Price: $89.64 Exercisable: N/A | Expires: 2028-02-20 Shares Owned After: 5,024 | Ownership: D (Direct) Footnotes: [F1] This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. [Transaction #2] Security: Stock Option (Right to Buy) Date: 2026-09-14 | Code: M (Exercise of derivative) Shares: -2,500 | Price: $0.00 Exercise Price: $89.64 Exercisable: N/A | Expires: 2028-02-20 Shares Owned After: 2,524 | Ownership: D (Direct) Footnotes: [F1] This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. [Transaction #3] Security: Stock Option (Right to Buy) Date: 2026-09-15 | Code: M (Exercise of derivative) Shares: -2,524 | Price: $0.00 Exercise Price: $89.64 Exercisable: N/A | Expires: 2028-02-20 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. --- Footnotes (Complete Index) --- F1: This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. --- Signature --- /s/ /s/ Louis Lalli, as an agent for Annette Favorite (2026-09-15)

keid analysis is for reference only and does not constitute investment advice.